Avodart® Reduces Prostate Cancer Risk - Cancer Consultants





<img alt="" height="1" width="1"><img src=http://nt1.ggpht.com/news?imgefp=-ZQS3Y1IUI4J&imgurl=newsimg.bbc.co.uk/media/images/45699000/jpg/_45699901_prostate.jpg width=80 height=60 alt="" border=1>

BBC News
Avodart® Reduces Prostate Cancer Risk

Cancer Consultants

Among men at increased risk of developing prostate cancer, use of Avodart® (dutasteride)—a drug currently used to treat benign prostatic hyperplasia— decreased the risk of prostate cancer by 23%.

AUA: Statin Benefits Linked to Prostate Cancer, BPH, ED MedPage Today

Glaxo drug cuts risk of prostate cancer Reuters

New York Times - WebMD - Wall Street Journal - SmartBriefall 624 news articles